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Abstract
Purpose: Pulmonary arteriovenous malformations (PAVM) are the direct communications between the pulmonary 
arteries and veins. These malformations can cause serious complications, and most of these patients should be treated. 
Herein we present our experience in the treatment of 18 cases of PAVM, treated with endovascular embolisation.
Material and methods: Eighteen patients with PAVMs underwent endovascular embolisation during a five-year period. 
Eight were male and 10 were female, with ages ranging from 16 to 65 years. Standard steel coils and vascular plug 
were used for embolisation.
Results: Embolisation was successful in 17 of 18 patients. Coiling was used in 10 patients, vascular plug in five, and 
both materials in two patients. All symptomatic patients with successful embolisation lost all their symptoms after 
treatment. Control angiography after embolisation showed a closure of AV shunt without migration of embolic ma-
terial in all patients. Post-embolisation syndrome developed in four patients and late onset of pleural pain in three 
patients. There was no connection between pleural reaction and type of PAVM and embolic material. 
Conclusions: Endovascular PAVM treatment is a minimally invasive, highly successful method with a low rate of only 
transitory complications. 
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Introduction
Pulmonary arteriovenous malformations (PAVM) are rare 
lesions, caused by abnormal communications between the 
pulmonary arteries and veins, right-to-left shunt, causing 
decreased oxygenation of the arterial blood [1]. There are 
two types of PAVMs: simple and complex. Simple types 
(approx. 80%) have a single feeding artery and a single 
draining vein, whereas complex types (20%) have two or 
more of each [2,3]. Patients with PAVM can be asympto-
matic for a long time, but they usually present with hypo-
xaemia and polycythaemia, mostly recognised by exercise 
intolerance and drumstick fingers [4]. These lesions are 
confirmed to be rarely sporadic, as it has been reported 
– between 60 and 90% are congenital manifestations of 
autosomal dominant syndrome called hereditary haemor-
rhagic telangiectasia (HHT) [1,4-6]. Neurological events 
such as transient ischaemic attack (TIA), stroke, and cere-
bral abscess, the result of paradoxical embolisation, occur 
in 30-40% of patients with untreated PAVM [7-9]. These 
events are considered the main reasons for intervention. 
It is generally recommended that feeding arteries of > 3 mm 
be occluded to prevent paradoxical embolisation, even in 
asymptomatic patients [9-11]. The 3-mm threshold is a rel-
atively arbitrary criterion, chosen when embolisation of 
smaller lesions was technically impractical. Currently, some 
interventional radiologists will treat all lesions identified on 
pulmonary angiography [12]. The conventional treatment 
of PAVM is surgical intervention, with all the complications 
that surgical procedure carries. That brings us to endovas-
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cular embolisation, which we aim to present through our 
experience with 18 cases treated at our institution, with ad-
vantages over surgery such as a reliable therapeutic effect, 
a low complication rate, and reproducibility [1,5,8].
Material and methods
During the last five years, 18 patients with PAVM had 
endovascular embolisation in the Clinical Hospital Merkur. 
The study was approved by the Ethics Committee, and each 
patient gave informed consent before inclusion in the study. 
Among them, eight (44.4%) were male and 10 (55.6%) were 
female, with ages ranging from 16 to 65 years with a medi-
an of 40 years (Table 1).
Indications for embolisation were diameter of the 
feeding artery lager than 3 mm, lesion larger than 2 cm, 
lesion with tendency for enlargement, and patients with 
neurological complications. Contraindications were res-
piratory tract infection, absolute contraindication for an-
giography, and pulmonary hypertension.
Only half of our patients were symptomatic. Three 
patients were presented with cerebral abscess, two with 
epistaxis, cyanosis was main physical sign in two cases, 
and exertional dyspnoea in two cases. In nine patients 
PAVMs were found during routine health examinations 
– by follow-up of previously reported chest X-ray abnor-
malities and dyspnoea with blood-saturation test abnor-
malities. HHT was associated in only two cases. No signif-
icant comorbidities were found in our patients.
Preoperative examination included laboratory exam-
inations such as: routine blood, urine, liver and kidney 
function tests, blood coagulation tests, and blood oxygen 
saturation measurement. All patients had cardiological 
examination and chest X-ray. Enhanced chest multide-
tector computerised tomography (MDCT) scans were 
performed in 15 patients. Digital subtraction angio-
graphys (DSAs) were performed before embolisation in 
three patients without MDCT scan in our institution, 
because they had had a recent scan performed at other 
institutions. Selective right and left pulmonary arterio-
graphy and super selective segmental arteriography were 
performed. Five patients had MDCT scan and DSA be-
fore intervention, due to better visualisation of feeding 
vessels.
Table 1. Presentation of all patients according to age, gender, symptoms, type of pulmonary arteriovenous malformations, embolisation material, and 
success of intervention with follow-up results during a period of one year
Case Age
(years)
Gender Symptoms Type and number 
of PAVM
Embolisation
material
Technical
success
Follow-up
1 months
Follow-up
6 months
Follow-up
12 months
1 53 Female HHT 1 complex Coils Yes Asymptomatic Asymptomatic Asymptomatic
2 38 Male Cyanosis 1 simple Coils Yes Asymptomatic Asymptomatic Asymptomatic
3 16 Female HHT 2 complex,  
1 simple 
Coils Yes Pleural pain 
and effusion (MDCT)
Asymptomatic Asymptomatic
4 29 Female None 1 simple Amplatzer Yes Asymptomatic Asymptomatic Missing
5 58 Male None 1 simple Amplatzer Yes Asymptomatic Asymptomatic Asymptomatic
6 40 Male Cyanosis 1 complex Amplatzer Yes Asymptomatic Pleural pain 
(MDCT)
Pleural pain 
(MDCT)
7 38 Female None 1 simple Coils Yes Asymptomatic Asymptomatic Missing
8 32 Female None 1 complex Coils Yes Asymptomatic Asymptomatic Asymptomatic
9 27 Male None 1 complex Amplatzer + coils Yes Pleural pain (MDCT) Asymptomatic Asymptomatic
10 22 Female Abscess 1 complex Coils Yes Asymptomatic Asymptomatic Asymptomatic
11 39 Female Dyspnoea 1 simple Coils Yes Pleural pain, 
caugh (MDCT)
Asymptomatic Asymptomatic
12 38 Female None 1 simple Coils Yes Asymptomatic Missing Missing
13 47 Male None  1simple Amplatzer + coils Yes Asymptomatic Asymptomatic Asymptomatic
14 49 Male None 1 simple Amplatzer Yes Asymptomatic Asymptomatic Asymptomatic
15 54 Male Dyspnoea 1 complex None No Missing Missing Missing
16 65 Female Abscess 1 simple Amplatzer Yes Pleural pain, effusion, 
temperature (MDCT)
Asymptomatic Pleural pain 
(MDCT)
17 61 Female None 1 complex Coils Yes Asymptomatic Asymptomatic Pleural pain 
(MDCT)
18 59 Male Abscess 1 simple Coils Yes Asymptomatic Asymptomatic Asymptomatic
MDCT – multidetector computerised tomography, Coil – pushable coils 5-14 mm, Amplatzer – vascular plug, CVI – cerebrovascular incident, HHT – hereditary haemorrhagic telangiectasia
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During the procedure continuous monitoring of the 
electrocardiogram was done due to a risk of cardiac dys-
rhythmia. Also, blood pressure, respiration, and blood 
oxygen saturation were carried out during the interven-
tion.
DSA and embolisation were made in all patients on 
a digital flat-panel angiography instrument (Shimatzu, 
Bransist Safire). A standard right femoral approach with 
an angled pigtail 5F (Terumo) for diagnostic right or 
left pulmonary arteriography was used in all cases. For 
a super selective segmental arteriography of feeding pul-
monary arteries a different type of catheter was used. 
The lower lobe vessels, which were the most frequent site 
of PAVM, was catheterised by a curved catheter such as 
a Bernstein (Boston Scientific) catheter. In cases of dif-
ficult approach to the lesion, once a feeding artery was 
catheterised, a guiding 6F catheter was placed in the par-
ent segmental vessel to insure the stability of access and 
reduce the possibility of cardiac dysrhythmia. Oblique im-
aging was obtained from different angles to get an exact 
anatomy and size of the feeding artery, and in two cases 
we used 3D rotational angiography.
Heparin sodium was injected through a peripheral 
vein before embolisation. Percutaneous transcatheter em-
bolisation was performed with two types of embolic mate-
rial: coil and vascular plug. Embolic material was placed as 
close as possible to the venous part of the PAVM to reduce 
chances of recanalisation through the collateral circula-
tion. We used pushable coils (Cook) with size from 5 to 
14 mm. The diameter of the coil was equal to or 10% larger 
than the diameter of the feeding artery (Figure 1). Two 
techniques of embolisation were used: “anchor” and “scaf-
fold”, to reduce the risk of coli migration. In the anchoring 
technique the coil tip is anchored in a small side-branch 
proximal to the actual malformation, and the body of the 
coil then prolapses into the feeding vessel. In the scaffold 
technique a larger coil is used initially to create a scaffold 
into which smaller coils can be placed to build up the coil 
nest. In patients with complicated vascular anatomy, such 
as large or short feeding artery, an Amplatzer vascular plug 
II (St. Jude Medical, AGA Medical Corporation) was used 
because the screw mechanism of release allows precise de-
ployment and reposition (Figure 2). 
The follow-up intervals of one, six and, 12 months 
included clinical examination, routine blood tests, blood 
oxygen saturation, and chest X-ray in all 17 patients. In 
the case of symptom appearance in the follow-up peri-
od, coil migration reported on chest X-ray, or abnormal 
oxygen saturation test, contrast-enhanced thorax MDCT 
was planned. Because all of our patients already required 
long-term monitoring, we decided that the radiation risk 
of multiple MDCTs during the follow-up period was too 
high, which is why we did not perform MDCT follow-up 
in any of our patients.
The data were analysed using descriptive test, chi-
square test; Statistica for Windows Release 7.0 Statsoft, 
Figure 1. Colling of the left lower lobe simple pulmonary arteriovenous 
malformations
A
B
C
Tulsa, Oklahoma, USA. All p values less than 0.05 were 
considered to indicate statistical significance.
Results
Simple PAVMs were found in 10 patients (56%) and com-
plex lesion with blood supply of the lesion from more than 
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two segmental arteries or veins in eight patients (44%). 
Single PAVM lesions were found in all cases except one 
who had three lesions: one simple and two with more than 
two feeding arteries (Table 1).
We managed to perform successful embolisation in all 
patients except one who had extreme tortuosity of parent 
vessels, so it was impossible to make a safe embolisation. 
The coils were used in 10 (58.8%) patients (Figure 1). 
Amplatzer vascular plug was used in five (29.4%) patients 
(Figure 2). In two (11.8%) patients both vascular plug and 
coils were used. One of them had two feeding arteries; 
one was closed with coils and another with an Amplatzer 
plug. In a second patient, after the feeding artery had been 
closed with a vascular plug, control angiography showed 
a small feeding artery, which was closed with coils. In all 
patients control pulmonary angiography after embolisa-
tion was performed (Table 1).
Control angiography after embolisation showed in 
all patients a closure of AV shunt without migration of 
embolic material (Figure 3). A normal vascular anatomy 
nearby the lesion was preserved. 
All symptomatic patients with successful embolisa-
tion lost all their symptoms after treatment. Post-embo-
lisation syndrome was present in four (23.5%) patients. 
In all four patients mild chest pain occurred a few days 
after the embolisation with small pleural effusion in two 
(11.8%) patients. One of the patients with pleural effusion 
had also a high temperature. A cough was present in one 
patient with pleural pain. The late onset of pleural pain 
occurred in three (17.6%) patients. Pleural pain started 
four months after embolisation in one patient, and in two 
patients after one year. One of the patients with late onset 
of pleural symptoms had also pleural effusion in the early 
post-embolisation period (Table 1). 
Contrast enhanced thorax MDCT was done in six 
(35.2%) patients with a pleural reaction symptom (Table 1). 
In four patients, MDCT was made one month after em-
bolisation, in one after six months, and in three patients 
one year after embolisation. Two of these patients had 
MDCT twice. One of them had pleural effusion in the ear-
ly post-embolisation period and late onset of pleural pain 
after one year, and another had MDCT six months and 
one year after embolisation due to pleural pain (Table 1). 
Pleural effusion was found on thorax MDCT in two pa-
tients with pleural pain in the early post-embolisation 
period (follow-up one month). There was no patholog-
ical change on thorax MDCT in patients who developed 
symptoms in the late post-embolisation period. In most 
patients the post-embolisation symptoms disappeared in 
a short period, regarding only symptomatic treatment. 
Only one patient with pleural effusion and a high tem-
perature received antibiotic therapy.
After the embolisation blood oxygen saturation in-
creased to normal levels in all patients without signs of 
hypoxemia. In all patients, the follow-up chest X-ray 
showed either complete disappearance of PAVM or its 
replacement with fibrous structure. The embolic material 
stayed in the same position during follow-up. 
There were no significant differences between simple 
and complex PAVM lesions regarding embolic materi-
al (χ2 = 1.31, p = 0.52) and clinical outcome (χ2 = 1.32, 
p = 0.25). Post-embolisation syndrome did not show con-
nection with type of PAVM (χ2 = 0.42, p = 0.52), embol-
ic material (χ2 = 0.88, p = 0.64), or symptomatic PAVM 
(χ2 = 1.29, p = 0.26). The same was true with the late onset 
pleural pain that was not connected with embolic material 
(χ2 = 2.86, p =0.24), type of PAVM (χ2 = 0.42, p = 0.51), 
and symptomatic PAVM (χ2 = 0.14, p = 0.71). 
Discussion
Pulmonary arteriovenous malformations (PAVMs) 
are direct communications between pulmonary arteries 
and veins. It is a rare disorder with the incidence of 2-3 
per 100,000 population [13]. PAVMs are usually congen-
ital malformations but rarely may be acquired. It is more 
frequent in females, and the male-to-female ratio varies 
from 1 : 1.5 to 1 : 1.8 [14]. In our study, female gender was 
A B
Figure 2. Embolisation of the right lower lobe simple pulmonary arteriovenous malformations with vascular plug
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more frequent also, but the ratio was not very high. Most-
ly PAVM were simple, consisting of a single feeding artery 
and single draining vein, as is usual in cases of PAVM. 
The proportion of complex type PAVM, which has two or 
more feeding arteries or drainage veins, was 44% in our 
patients, which is higher than in most published studies 
[1-5,13]. The type of PAVM did not have any influence on 
the embolisation outcome. Most PAVMs were single and 
localised to the lower lobes, as is usual for PAVM.
PAVMs caused right-to-left shunt, which, if small, will be 
clinically silent. In different studies asymptomatic patients 
account for between 13 and 55% of all patients [14-16]. 
Almost half of our patients were asymptomatic. Symp-
toms develope when right-to-left shunt exceeds 25% of 
total blood volume. Decreased blood oxygenation caused 
symptoms of hypoxaemia such as cyanosis and dyspnoea, 
as we saw in some of our patients. If high shunt flow is 
present, it will result in an increased cardiac output and 
heart failure at the end, which did not occur in our study.
PAVM should be considered in differential diagnosis 
of young patients with cerebral abscess, TIA, or stroke. 
PAVM also should be excluded in patients with unex-
A
B
Figure 3. A) Angiography before embolisation. B) Digital subtraction angiography and maximum intensity projection reconstruction of contrast enhanced 
thorax multidetector computed tomography after pulmonary arteriovenous malformations embolisation
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plained hypoxia or cyanosis, and in first-degree family 
members with HHT. Hereditary haemorrhagic telangiec-
tasia (HHT) is an inherited disorder of the vasculature 
associated with arterio-venous malformation and telangi-
ectasias. Approximately 70% of PAVM cases are associated 
with HHT, but only 25-30% of patients with HHT have 
pulmonary AVM due to different genetic mutations re-
sponsible for the disease [17,18]. In our study we had only 
two patients with HHT; the diagnosis of HHT was made 
by clinical symptoms known as Curacao criteria (epistax-
is, mucocutaneous telangiectasia, and PAVM) [19].
Severe cerebrovascular incidents such as TIA, stroke, 
and cerebral abscess occur in 30-40% patients [7-9]. 
The mechanisms are mostly paradoxical embolism from 
systemic thrombus, but also lack of filtration and increased 
blood viscosity can cause cerebral accidents. Although cer-
ebral abscess is an initial symptom of PAVM, in 5-14% of 
patients in our study it was the main cerebral event [13,20]. 
A possible explanation for this is a non-sterile thrombus 
from the vein due to thrombophlebitis in two patients. In 
one patient the probable explanation was earlier pulmo-
nary infection near the vascular malformation.
These malformations can caused serious complica-
tions, and there is an evidence-based indication to treat 
these patients. In untreated patients, according to pub-
lished data, morbidity is the range 26-33% and mortality 
from 8 to 16% [18]. The risk for central nervous system 
complications is significant in all PAMs with a feeding ar-
tery ≥ 3 mm, so this characteristic of the lesion demanded 
treatment regardless of symptoms [9-11,17].
Chest X-ray is not an adequate diagnostic tool for 
PAVM because some PAVMs are not visible on chest 
X-ray, depending on the size and location. We made 
MSCT angiography or DSA in all our patients before in-
tervention because these methods are highly sensitive in 
PAVM diagnostics and can precisely show afferent and 
efferent vessels [21-23]. In the same case we used both 
methods to make an exact visualisation of the feeding 
vessel, and in two patients 3D rotational angiography was 
used. Exact measurement of the feeding vessel is neces-
sary to choose the right embolisation material that pre-
vents a paradoxical embolisation or PAVM recanalisation.
Today, embolisation is the method of choice in the 
treatment of PAVM, due to its high success rate and only 
a few complications [1,5,11,24]. Also, embolisation is 
a minimally invasive procedure, which requires only local 
anaesthesia and significantly shorter time of hospitalisa-
tion compared to surgical treatment. Technical success of 
embolisation with occlusion of the feeding artery can be 
achieved in 95-100% of cases. We managed to occlude the 
feeding artery in all cases except one patient in whom it 
was impossible to safely catheterise the feeding vessels.
 Recanalization is always is possible from adjacent 
pulmonary arteries. Recanalisation after use of coils has 
been described in 8-16% of cases [25,26]. There were 
no recanalisations in our patients during the 12-month 
control period. We always used the “anchor” or “scaffold” 
technique, which reduced the recanalisation rate. Failure 
of endovascular treatment of PAVM occurs mostly with 
large and short feeding vessels, due to catheter instability 
during the procedure and high risk of coil migration. Sur-
gery is a safe option for large, single, and centrally located 
lesions [27]. Currently, new techniques such video-assist-
ed thoracoscopy are being used.
The most serious complication of endovascular treat-
ment is paradoxical embolisation, with an incidence of 
0.5-2.5% [13,28,29]. Paradoxical embolisation occurred 
due to an overly large orifice of the malformed vessel, short 
neck of the feeding artery, small diameter of embolic ma-
terial, or high blood flow rate. Exact measurement of the 
feeding vessel size and appropriate embolisation material 
is crucial to avoid this complication. In the case of difficult 
anatomy we used a few selective angiograms of the PAVM 
from different angles, to make the most precise measure-
ment of the feeding artery. The size of the embolic mate-
rial was ≥ 10% larger than the size of the feeding artery 
in our study. Much larger size of embolic material would 
be absolute insurance against paradoxical embolisation, 
but it would be impossible to perform correct curling of 
the coil inside the feeding artery and its complete occlu-
sion. Coils are flexible, and they are preferred in tortuous 
and small calibrated vessels. For short and large feeding 
vessels we used an Amplatzer device [30,31]. It is a self- 
expandable cylindrical nitinol wire-mesh occlusion device, 
which is detachable and can be repositioned very precisely 
with safe controlled detachment. We manage the problem 
of fast blood flow also using an Amplatzer vascular plug. 
In the case of fast blood flow, a temporary occlusion of the 
proximal part of the feeding vessel can be achieved by using 
a balloon catheter. Another solution in the case of short and 
large feeding vessel or fast flow could be the use of a cov-
ered stent [1]. We did notice migration of embolic material 
in or patients during procedure and in flow-up period. 
Post-embolisation syndrome is result of a body re-
action to tissue infraction. As part of post-embolisation 
syndrome, slight to moderate chest pain and transient low-
grade fever occurred in 10-15% of patients [4,9,12]. Pleural 
reaction usually starts in the first few days after embolisa-
tion. It is self-limited and usually stops during the subse-
quent 4-7 days. In our study four patients had post-embo-
lisation syndrome in the first week after embolisation, and 
two of them developed pleural effusion. One patient who 
had a high fever was treated with antibiotics and another 
needed only short pain-relief therapy. Unusually, we had 
one patient who developed pleural pain after four months, 
and three patients one year after embolisation. In cases of 
pleural symptoms with routine chest X-ray, patients had 
also thorax MDCT. MDCT was normal in all symptomatic 
patients except in two of them, who had pleural effusion 
in the early post-embolisation period. We did not find 
a connection between the pleural reaction and the type of 
the PAVM or embolic material. An Amplatzer device was 
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more frequently used in patients with late onset of pleural 
symptoms but without significant difference. 
All patients with successful embolisation experience 
experienced disappearance of their symptoms with higher 
functional level.
Conclusions
Embolisation should be the first choice in PAVM treat-
ment because it is a minimally invasive, highly successful 
method with a low rate of only transitory complications. 
Development of a new embolic material such as vascular 
plug makes embolisation possible in almost all patients 
independently of vascular anatomy.
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